Research Advances

Tumor-infiltrating lymphocyte (TIL) therapy is a personalized immunotherapy that uses a patient’s own immune cells to fight cancer. T cells are collected from a tumor, expanded in the lab using growth factors like Interleukin-2, and reinfused after lymphodepleting chemotherapy, followed by additional IL-2 support to boost activity. This approach is promising for non-small cell lung […]